Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
about
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.Cellular mechanisms underlying the pharmacological induction of phosphenesHCN channels and heart rateIvabradine, coronary artery disease, and heart failure: beyond rhythm controlFunny channel gene mutations associated with arrhythmiasNovel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.A low-cost, portable, high-throughput wireless sensor system for phonocardiography applications.Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Ivabradine for the treatment of stable angina pectoris in octogenarians.Atrioventricular node ablation and pacemaker implantation for recurrent syncope in a patient with postural tachycardia syndrome (POTS).Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study.Ivabradine: the evidence of its therapeutic impact in angina.Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study.Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathyResting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?The Contribution of HCN4 to normal sinus node function in humans and animal modelsChronic heart failure, chronotropic incompetence, and the effects of beta blockadeChronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study.The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome PatientsCa2+-activated adenylyl cyclase 1 introduces Ca2+-dependence to beta-adrenergic stimulation of HCN2 current.What keeps us ticking: a funny current, a calcium clock, or both?Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in miceDrug insight: If inhibitors as specific heart-rate-reducing agents.Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor.Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography.Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbitsThe pacemaker current: from basics to the clinics.Absence of respiratory effects with ivabradine in patients with asthma.Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.Ivabradine: a new strategy for management of stable angina.Evaluation of aggressive heart rate reduction in patients with stable angina.Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats.Genesis and regulation of the heart automaticity.Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.Control of heart rate by cAMP sensitivity of HCN channels
P2860
Q24544613-15ED1CF3-738D-455C-8DDC-0FB2BAF6DEA1Q24681601-1982DA4B-4BC1-41EB-86AA-0A54A35345C9Q26859318-CA5C82B4-4B35-4062-8ED9-808DCBB7AA44Q26865770-E4C7E931-D15A-4FB1-8DEC-F3EEDC6BB9EBQ26999230-A06B111F-0176-4AA2-B53D-F549734FFB23Q28576826-5B356E00-C770-440A-9236-0F9C7EA6B13AQ30318221-5F6BD2D0-F511-4245-858F-05A646C2D39CQ30462128-766AE96C-F2D4-461F-83FC-F3D8B9D93B15Q30498016-FB9A7693-367A-4817-A046-94F4049302EAQ30583012-1DE110CE-DCAE-4EE6-AB0B-39F9F5AA8AA9Q33159163-9D349CBF-55A8-4DB8-9B2E-CDD54C8BF367Q33159999-A63495C7-AE44-47C7-9CB4-1944D5FBAB8DQ33162534-3C4AA0B0-90BA-420F-B4F7-B5D4AB52E62CQ33163797-AF0EFD79-8878-4684-9D54-FD0E40C1591FQ33973963-6DB42BC1-3905-420D-9F21-91CB370A855AQ34339990-460DB80F-AFC0-4A76-B741-AC5378396CDAQ34387839-84093E26-5B86-4311-B161-3110A9B30C60Q34774214-F79002AB-674B-4280-8F16-0944E7A68886Q35005962-87701A1F-744A-40A8-9F2B-5ED28F96D877Q35771500-25DF6342-EE1C-4AC1-B062-A3148F2E0517Q35851594-3E503CDB-C320-4594-943A-A52A1CFA9C0AQ35914816-9F458A0B-D8E4-4052-966A-4DD2C28F834EQ35947167-2CE35B86-8747-42D7-BD2F-5D6F00B777FAQ36010630-121C47D1-E4F8-447A-A8D0-F509E9C12ACFQ36059223-6CBAEED6-339F-4482-BF6A-94A716B07DEEQ36116647-51F46112-0D04-4E99-AC52-32DBF1EFC39DQ36304200-7D0F9B98-CEC3-405C-946B-C2618C8C247FQ36351531-28573588-76B0-4B04-B286-7D678F6E1708Q36361206-C8CF12D9-6190-431E-8939-CF005EBDB2CDQ36412437-9740EFB0-42D4-449E-93E8-089898B4BD9EQ36729727-F2E48007-71D9-4F60-AD0D-01D3E79137A6Q36792707-D9F39122-9A67-4C07-96AF-7FC82DBADA7AQ36877742-0CFE7AB0-6A75-40BF-BBF4-13A19C21D1C4Q36886149-2E596CAB-FBCA-4D0D-A3E4-CD8A296E978CQ37055832-1DFE8976-A772-4024-8D51-9EEB0C483439Q37068649-AA250CD1-0879-4FF1-82BC-ADEDA5C640F4Q37126021-A0C60E6D-EF32-4380-AF03-1C40C7C93B09Q37216067-4262844F-236C-4EBF-80B7-351C02B90511Q37250491-FEAB011D-2165-48FB-9633-701EF80A88AFQ37274509-B0DB6628-7E54-4B51-8D0A-517570D3668B
P2860
Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@ast
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@en
type
label
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@ast
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@en
prefLabel
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@ast
Heart rate lowering by specifi ...... ive in cardiovascular disease.
@en
P1433
P1476
Heart rate lowering by specifi ...... tive in cardiovascular disease
@en
P2093
John A Camm
P304
P356
10.2165/00003495-200464160-00003
P577
2004-01-01T00:00:00Z
P6179
1027485447